---
category: news
title: "GT Apeiron Announces Enrollment of First Patient in Phase 1/2 \"ELUCIDATE\" Clinical Trial of CDK7 Inhibitor, GTAEXS617, in Advanced Solid Tumors"
excerpt: "Preclinical data from AI-optimized GTAEXS617 support potential for improved therapeutic index compared to other CDK7 inhibitors under development - - Parallel translational initiative to evaluate preclinically identified non-invasive PD biomarkers with potential to predict GTAEXS617 treatment responders - SAN FRANCISCO and SHANGHAI,"
publishedDateTime: 2023-07-10T11:17:00Z
originalUrl: "https://technews.tmcnet.com/news/2023/07/10/9844912.htm"
webUrl: "https://technews.tmcnet.com/news/2023/07/10/9844912.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "3pbJV47+KT4BHCRJIFhJP/L0DzAkJyAIT7uoEG/z2pS6G/bomiXXObLWZp051gFqog6pwl2Yl93w9Q+l8MW9RtkOW6Dz27wARlgn9cjJfQVS+wkjdE0xP9t/x2tfQd1o86b+Sywf1yozrJokO769791lx46gZigUC+5lhD7AX3M9IjmFPV7KI+BXueidPPYjeRaxrR7fI5HPQagX49e8WbX5jgW/9Fc37yGGnWPR3GW+81paQMZOlA3B6LGR/yzt4qJ8cHiX6g4HeHmL5fkLcowQ+Btu7B6N8vYye2jydpAsQ2+YLXWvaqIEvptJ1s9/Km8QMz/CBCF6mrMuNbKbckZI30PG4x6gl2TixoIQZN4=;jv6b96baNwzg6ouH3J7O7g=="
---

